(Press-News.org) Philadelphia, Pa. (September 16, 2013) – The hormone oxytocin could play a role in treating psychiatric disorders such as autism and schizophrenia, according to a review article in the September Harvard Review of Psychiatry. The journal is published by Lippincott Williams & Wilkins, a part of Wolters Kluwer Health.
Among other biological effects, oxytocin is "an important regulator of human social behaviors," according to the research review by Dr David Cochran of University of Massachusetts Medical School and colleagues. They discuss the preliminary but encouraging evidence that oxytocin could be a useful treatment for certain mental health diagnoses—particularly those involving impaired social functioning.
A Common Hormonal Factor in Psychiatric Disorders?
Oxytocin is a neuropeptide hormone, probably most familiar for its role in initiating labor and breast milk flow in pregnant women. But a growing body of evidence in animals and humans shows that it also plays an important role in regulating social behaviors. In their review, Dr Cochran and colleagues found evidence of oxytocin's involvement in "social decision making, evaluating and responding to social stimuli, mediating social interactions, and forming social memories" in humans.
Based on these effects, researchers have suspected that oxytocin may be a common factor in certain psychiatric disorders. The reviewers analyze the evidence for oxytocin's involvement in specific disorders—including some early research on oxytocin as a potential treatment for these conditions.
Some studies have reported a "dysfunction in oxytocin processing" in children (although not necessarily adults) with autism and related disorders. There's also evidence that genes affecting oxytocin—such as the oxytocin receptor gene, OXTR—may be involved in the development of autism spectrum disorders.
Possible Treatment Benefits in Autism and Schizophrenia
Based on initial trials, oxytocin may one day "be a useful treatment agent for improving some aspects of social cognition and for reducing repetitive behaviors" in patients with autism spectrum disorders, although studies are only in the early stages to fully evaluate clinical effectiveness. The authors discuss a case report of significant reductions in autism severity with oxytocin, and the only controlled trial of long-term oxytocin treatment showed improvement in identifying emotions and quality of life measures.
Studies of oxytocin's relationship to schizophrenia have yielded conflicting results—associations with oxytocin-related genes don't appear as strong as for autism. Nevertheless, some studies have suggested that oxytocin might be a helpful treatment for patients with schizophrenia, with trials reporting encouraging effects on schizophrenia severity and on social cognition.
Because oxytocin is involved in responses to stress, studies have also looked at its potential role in mood disorders and anxiety disorders. For example, there's evidence that oxytocin may be involved in beneficial responses to electroconvulsive therapy for severe depression.
But so far, there's little evidence that oxytocin is a useful treatment for anxiety and depression. The same is true for early studies of oxytocin for treatment of obsessive-compulsive disorder and borderline personality disorder.
On balance, "The evidence suggests a role of oxytocin in the pathophysiology of some psychiatric disorders, particularly those characterized by impairments in social functioning," Dr Cochran and coauthors write. "However, the preliminary nature of the currently available data precludes a clear understanding of the exact nature of this role."
Thus despite some promising results, it's much too early to conclude that oxytocin is a helpful treatment for autism, schizophrenia, or any other psychiatric disorder. Even if the evidence were stronger, there's currently no reliable way of giving oxytocin treatment so that it gets to the brain in a predictable way. Nasal administration seems to be the most promising alternative, but larger studies are needed to understand how it gets to the brain receptors necessary for its effects.
Meanwhile, researchers will continue their attempts to clarify oxytocin's role in psychiatric disorders and the effects of treatments targeting this essential hormone. Dr Cochran and colleagues conclude that "proper clinical trials are only recently being undertaken," which "should provide a better understanding of the extent and limitations of the clinical effects of externally delivered oxytocin."
###
About the Harvard Review of Psychiatry
The Harvard Review of Psychiatry is the authoritative source for scholarly reviews and perspectives on a diverse range of important topics in psychiatry. Founded by the Harvard Medical School Department of Psychiatry, the journal is peer-reviewed and not industry sponsored. It is the property of Harvard University and is affiliated with all of the Departments of Psychiatry at the Harvard teaching hospitals. Articles encompass all major issues in contemporary psychiatry, including (but not limited to) neuroscience, psychopharmacology, psychotherapy, history of psychiatry, and ethics.
About Wolters Kluwer Health
Wolters Kluwer Health is a leading global provider of information, business intelligence and point-of-care solutions for the healthcare industry. Serving more than 150 countries and territories worldwide, Wolters Kluwer Health's customers include professionals, institutions and students in medicine, nursing, allied health and pharmacy. Major brands include Health Language®, Lexicomp®, Lippincott Williams & Wilkins, Medicom®, Medknow, Ovid®, Pharmacy OneSource®, ProVation® Medical, and UpToDate®.
Wolters Kluwer Health is part of Wolters Kluwer, a market-leading global information services company. Wolters Kluwer had 2012 annual revenues of €3.6 billion ($4.6 billion), employs approximately 19,000 people worldwide, and maintains operations in over 40 countries across Europe, North America, Asia Pacific, and Latin America. Follow our official Twitter handle: @WKHealth.
END
This news release is available in German. Today, most information is transmitted by light – for example in optical fibres. Computer chips, however, work electronically. Somewhere between the optical data highway and the electronic chips, photons have to be converted into electrons using light-detectors. Scientists at the Vienna University of Technology have now managed to combine a graphene photodetector with a standard silicon chip. It can transform light of all important frequencies used in telecommunications into electrical signals. The scientific results have ...
A new study led by the Johns Hopkins Bloomberg School of Public Health finds that during a decade when prescription opioid use has skyrocketed, the identification and treatment of pain has failed to improve, and the use of non-opioid analgesics has plateaued, or even declined. The study was published online September 13 in the journal Medical Care.
"There is an epidemic of prescription opioid addiction and abuse in the United States," notes G. Caleb Alexander, MD, MS, associate professor of Epidemology and Medicine and co-director of the Johns Hopkins Center for Drug ...
In co-operation with a research group from Singapore, scientists at University of Copenhagen have shown that immature sugar molecules in the form of truncated O-glycans aid growth properties of cancer cells. Previously, scientists have not been able to decode the significance of these truncated O-glycans, and therefore, the results, which were recently published in the journal PNAS, represent an important contribution to understanding the growth of cancer cells as well as the work towards developing a cure that can limit or stop the growth.
Catharina Steentoft, PhD student ...
Philadelphia, PA, September 16, 2013 – Just as wires must be insulated to effectively carry electrical impulses, nerve cells must be insulated by myelin to effectively transmit neural impulses. Using typical magnetic resonance imaging or MRI, one can visually distinguish parts of the brain that look white and parts that look gray. Myelin is most prevalent in the white matter because this component of the brain tissue is principally comprised by the nerve cell projections (axons) that are covered by myelin and that transmit information from one part of the brain to another. ...
Electronic data routinely gathered in hospitals can be used as a warning system for missed doses of prescribed medicine and making improvements to patient safety, says a new study.
A team from the Universities of Leicester and Birmingham found that the secondary use of data from an electronic prescribing and decision support system in an English hospital led to a 'substantial and sustained' reduction in rates of missed or delayed doses of medicines.
Published in the world-leading health policy journal Milbank Quarterly, the study looked at how using the electronic ...
More than half of all patients with pre-existing dementia will experience delirium while hospitalized. Failing to detect and treat their delirium early leads to a faster decline of both their physical and mental health, according to health researchers.
"This study is important, as delirium is often overlooked and minimized in the hospital setting, especially in persons with dementia," said Donna M. Fick, Distinguished Professor of Nursing at Penn State and principal investigator for this study. "And it illustrates that delirium is deadly, costly and impacts patient functioning." ...
New research from the Niels Bohr Institute shows that cement made with waste ash from sugar production is stronger than ordinary cement. The research shows that the ash helps to bind water in the cement so that it is stronger, can withstand higher pressure and crumbles less. At the same time, energy is saved and pollution from cement production is reduced. The results are published in the scientific journal, Scientific Reports.
Cement is comprised of chalk and clay, which are mixed together and heated at high temperatures in a cement kiln. The mixture is then crushed ...
Researchers from North Carolina State University have developed a new theoretical model that will speed the development of new nanomaterial alloys that retain their advantageous properties at elevated temperatures.
Nanoscale materials are made up of tiny crystals, or grains, that are less than 100 nanometers in diameter. These materials are of interest to researchers, designers and manufacturers because two materials can have the same chemical composition but very different mechanical properties depending on their grain size. For example, materials with nanoscale grains ...
Scientists have discovered that a drug which increases the risk of sudden cardiac death interacts with mistranslated protein-coding genes present in heart muscle.
The cardiac drug flecainide was developed to prevent and treat serious arrhythmias in the ventricles - the main pumps of the heart. These cause very rapid heart rates which can be lethal if unchecked. However in clinical trials, flecainide, and its sister molecule encainide, were reported to more than double the risk of sudden cardiac death.
Joint work by researchers in the Department of Chemistry and Warwick ...
Scientists at the University of Warwick have modelled an outbreak of the bee infection American foulbrood in Jersey, using a technique which could be applied to other honeybee diseases such as European foulbrood and the Varroa parasite.
As well as modelling how bee infections spread, the method also allows scientists to simulate various disease control interventions in order to measure their efficacy.
The researchers used two sets of data gathered two months apart during an outbreak of American foulbrood in Jersey in the summer of 2010. This provided two 'snapshots' ...
